These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15228052)

  • 1. Remodeling as an end-point in heart failure therapy.
    Cohn JN
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):7-8. PubMed ID: 15228052
    [No Abstract]   [Full Text] [Related]  

  • 2. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.
    Remme WJ;
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):69-77. PubMed ID: 11504166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ
    Heart Fail Clin; 2005 Apr; 1(1):67-75. PubMed ID: 17386835
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of congestive heart failure. Has the time come for decreased complexity?
    Rydén L; Remme WJ
    Eur Heart J; 1999 Jun; 20(12):867-71. PubMed ID: 10329091
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitric oxide's role in heart failure: pathophysiology and treatment. Introduction.
    Cohn JN; Loscalzo J; Franciosa JA
    J Card Fail; 2003 Oct; 9(5 Suppl Nitric Oxide):S197-8. PubMed ID: 14653276
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS
    Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and reversal of left ventricular remodeling: summation.
    Konstam MA; Udelson JE; Sharpe N
    J Card Fail; 2002 Dec; 8(6 Suppl):S506-11. PubMed ID: 12555166
    [No Abstract]   [Full Text] [Related]  

  • 9. [Administration of beta blockers for chronic heart failure].
    Walma EP
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2325-6. PubMed ID: 11143301
    [No Abstract]   [Full Text] [Related]  

  • 10. Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure.
    Reis Filho JR; Cardoso JN; Cardoso CM; Pereira-Barretto AC
    Arq Bras Cardiol; 2015 Jun; 104(6):502-6. PubMed ID: 26131706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE
    Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in post-infarction ventricular remodeling.
    Udelson JE; Patten RD; Konstam MA
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
    Shimamoto K; Kawana M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for left ventricular remodeling in heart failure.
    Frigerio M; Roubina E
    Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to attenuate pathological remodeling in heart failure.
    Eapen Z; Rogers JG
    Curr Opin Cardiol; 2009 May; 24(3):223-9. PubMed ID: 19318933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenergic activation in heart failure: blockade or rebalance?].
    Emdin M; Vergaro G; Giannoni A; Passino C
    G Ital Cardiol (Rome); 2010 Mar; 11(3):229-32. PubMed ID: 20550063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.